Pleiotrophic and anti-inflammatory effects of pioglitazone precede the metabolic activity in type 2 diabetic patients with coronary artery disease

Autor: Forst, T., Karagiannis, E., Lübben, G., Hohberg, C., Schöndorf, T., Dikta, G., Drexler, M., Morcos, M., Dänschel, W., Borchert, M., Pfützner, A.
Zdroj: In Atherosclerosis 2008 197(1):311-317
Databáze: ScienceDirect